Dr. Hojnacki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 High St
Buffalo, NY 14203Phone+1 716-859-7051
Education & Training
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloDiagnostic Neuroimaging, 2007 - 2008
- University at BuffaloFellowship, Neuroimmunology & Multiple Sclerosis, 2006 - 2007
- University at BuffaloResidency, Neurology, 2003 - 2006
- University at BuffaloInternship, Internal Medicine, 2002 - 2003
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2002
Certifications & Licensure
- NY State Medical License 2008 - 2025
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 69 citationsHypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study.Dejan Jakimovski, Shipra Gandhi, Ivo Paunkoski, N. Bergsland, Jesper Hagemeier
European Journal of Neurology. 2019-01-01 - 115 citationsCardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosisNatalie Kappus, Bianca Weinstock-Guttman, Jesper Hagemeier, Cheryl Kennedy, Rebecca Melia
Journal of Neurology, Neurosurgery, and Psychiatry. 2015-02-26 - 14 citationsFingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients.Zohara Sternberg, Channa Kolb, Kailash C. Chadha, Adam Nir, Nir Raphael
Neuropharmacology. 2018-03-01
Journal Articles
- Brain Atrophy Is Associated with Disability Progression in Patients with MS Followed in a Clinical RoutineDavid Hojnacki, MD, American Journal of Neuroradiology
Press Mentions
- ‘Usual Suspect’ Lesions Appear Not to Cause Most Severe Disability in Multiple Sclerosis PatientsFebruary 25th, 2023
- MS Clinicians Listen up: Here’s How Your Patients Need You to Talk About Brain Atrophy with ThemNovember 14th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: